Get the tools used by (smart)2 investors.
SP500 -0.2%DOW -0.1%FTSE 100 -0.7%NIKKEI -0.2%OIL 0.1%GOLD -0.8%
Sign In
WatchlistsIdeasScreenerData ExplorerChartsSaved Work

Buyback Yield for Novartis AG ADR

Join now and get access to the full platform

Search for company or ETF

 

  0 results available. Select is focused ,type to refine list, press Down to open the menu,

NVS: Novartis AG ADR

Novartis AG engages in the research, development, manufacture, distribution, marketing, and sale of pharmaceutical medicines in Switzerland and internationally. The company offers Entresto, an angiote...

112.13 USD
Price
– USD
Fair Value
–
Upside
92.35 - 120.92
52-week range
Create ChartCreate ModelAdd To Watchlist

Analysis

Fiscal Years
Trailing Twelve Months
Fiscal Halfs
Fiscal Quarters
Daily
Hide this widget

The following section summarizes insights on Novartis AG ADR's Buyback Yield:

Dec 2016Dec 2018Dec 2020Dec 2022Dec 20241.0%3.0%5.0%7.0%
Performance Summary
  • Novartis AG ADR's latest twelve months buyback yield is 3.7%
  • Novartis AG ADR's buyback yield for fiscal years ending December 2020 to 2024 averaged 3.2%.
  • Novartis AG ADR's operated at median buyback yield of 3.7% from fiscal years ending December 2020 to 2024.
  • Looking back at the last 5 years, Novartis AG ADR's buyback yield peaked in December 2022 at 5.4%.
  • Novartis AG ADR's buyback yield hit its 5-year low in December 2020 of 1.0%.
  • Novartis AG ADR's buyback yield decreased in 2020 (1.0%, -60.7%), 2023 (4.1%, -23.9%), and 2024 (3.7%, -9.4%) and increased in 2021 (1.5%, +56.6%) and 2022 (5.4%, +255.6%).

How does Novartis ADR's Buyback Yield benchmark against competitors?

Hide this widget

We've identified the following companies as similar to Novartis AG ADR because they operate in a related industry or sector. We also considered size, growth, and various financial metrics to narrow down the list to the ones listed below.

Novartis ADR Buyback Yield Benchmarks
NameTickerBuyback Yield
HealthcareSECTOR:HLTH.CH0.0%
AstraZeneca PLCBRSE:000982352-
Johnson & JohnsonBRSE:000943981-
Pfizer IncDB:PFE0.0%
Bristol-Myers Squibb CoBRSE:BMY-
Teva Pharmaceutical Industries LimitedSWX:TEVA0.0%
GlaxoSmithKline PLCBRSE:001102657-
Sandoz Group AGSWX:SDZ0.1%
Eli Lilly and CoSWX:LLY0.3%
Roche Holding AGSWX:RO0.5%
Merck & Co., Inc.BRSE:0106830530.5%
Novartis AG ADRNYSE:NVS3.7%

Metric Usage: Buyback Yield

Hide this widget
buyback_yield
Slug
number
Datatype
text
Format
current
Default Period
FY, LTM
Periods Supported
Free
Plan

To view the full list of supported financial metrics please see Complete Metrics Listing.

Similar Metrics

Hide this widget

Metrics similar to Buyback Yield in the valuation category include:

View Full List

Search for metric or datapoint

Buyback Yield

A ratio that measures the difference between the amount of share repurchases and the amount of share issuances over the trailing twelve months divided...

Definition of Buyback Yield

Hide this widget

Buyback Yield is defined as:

Share Repurchases - Share Issuances
(/) Market Cap
(=) Buyback Yield

Buyback yield measures the difference between the amount of share repurchases and the amount of share issuances over the trailing twelve months divided by the company’s market capitalization

Read more about shareholder yield, net payout yield, and debt paydown yield

Click the link below to download a spreadsheet with an example Buyback Yield calculation for Novartis AG ADR below:

Sector Benchmark Analysis

All rights reserved. Terms Of Use